The Greater Bay Area Institute of Precision Medicine (Guangzhou) (English abbreviation: GBA-IPM) (hereinafter referred to as the "Institute") is a provincial-level public institution jointly established by the Guangzhou Municipal People's Government, the Administrative Committee of Guangzhou Nansha Economic and Technological Development Zone, and Fudan University. It is located in Nansha District, Guangzhou, the geographical center of the Guangdong-Hong Kong-Macao Greater Bay Area. On October 19, 2020, the Institute was registered with the Guangdong Provincial Public Institution Registration Administration.
The Institute will bring together domestic and international forces, leverage Fudan University's strong interdisciplinary research advantages, and the locational and innovative development strengths of the Greater Bay Area, especially Nansha, to promote the deep integration of the Yangtze River Delta and the Pearl River Delta. Focusing on cutting-edge precision medicine research and the application and transformation of major achievements, the Institute aims to build a world-class high-level new R&D institution, attract outstanding scientists and teams from home and abroad to settle in the Greater Bay Area, and plans to recruit 500 full-time professionals, including 50 high-level talents from home and abroad. In the core area of the Nansha Free Trade Zone, the Institute is planning to construct a research building, expected to be completed and put into use by the end of the 14th Five-Year Plan period.
The Institute is led by President Jin Li, an academician of the Chinese Academy of Sciences and President of Fudan University, with Professor Lin Xinhua, Dean of the School of Life Sciences at Fudan University and Director of the State Key Laboratory of Genetic Engineering, serving as Executive Director. The Institute focuses on precise prevention, diagnosis, and treatment of major diseases, establishing four research institutes: Genetic Diseases, Tumor Prevention and Treatment, Neurological Diseases, and Geriatric Health. It also focuses on major industrial technology directions, establishing eight research centers: Cell and Gene Therapy Research Center, Innovative Medical Device Research Center, Microbiology and Immunology Research Center, Organoids and Regenerative Medicine Research Center, Mitochondrial Genetics and Health Research Center, Original New Drug Research Center, Precision Diagnostics Research Center, and Intelligent Medicine Research Center. To provide high-end biomedical technical services, the Institute has established 11 high-level public technical service platforms: Organoids and Cell Therapy Platform, Molecular and Cellular Imaging Platform, Innovative Medical Device Platform, Nucleic Acid Omics Platform, Metabolomics Platform, Single-cell and Spatial Omics Platform, Precision Medicine Big Data Platform, Small Molecule Drug Public Instrument Platform, Microbiomics Platform, Public Experimental Platform, and Proteomics and Glycomics Platform. The Institute will also establish joint laboratories with high-level research institutions and leading enterprises in the Greater Bay Area, set up a series of innovation centers in biomedical industry clusters at home and abroad, form a global collaborative innovation network, and accelerate technology transfer and achievement transformation.
The Institute has been approved to build a Guangdong Provincial High-Level Innovation Research Institute and a Guangdong Provincial Postdoctoral Innovation Practice Base, jointly training postdoctoral researchers with Fudan University. Additionally, the Institute is a council member unit of the Greater Bay Area Precision Medicine Alliance and a founding and standing council member unit of the Guangzhou Nansha Science and Technology Achievement Transformation Alliance.
Looking ahead, the Institute will face the forefront of global biomedical science and technology, the major strategic needs of Healthy China, the main battlefield of serving the high-quality development of Guangdong Province and the Greater Bay Area, and the health of the people. It will strive for innovation and continuous output of internationally leading cutting-edge achievements and key technologies, make every effort to build a world-class precision medicine research center and talent highland, strive to cultivate an international precision medicine industrial cluster driven by source innovation, and contribute its strength to accelerating the formation of a global innovation highland for precision medicine and an important global source of emerging biotech industries in China and the Greater Bay Area!
We warmly welcome outstanding young and middle-aged scholars from home and abroad to join us!
What does Greater Bay Area Institute of Precision Medicine (Guangzhou) require? Who is Greater Bay Area Institute of Precision Medicine (Guangzhou) hiring? recruitment: 经营管理类占比最多占22.7%，其次是计算机/网络/技术类占22.7%. What education can get in at ? 硕士占比最多占54.5%，其次是博士占22.7%. High education required at ? 硕士占54.5%，博士占22.7%. Work experience required at ? 不限占比最多占40.9%，其次是5-10年占31.8%. Where are the job locations at ? 广州占比最多占81.8%，其次是上海占13.6%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
